Wound Care (Pharmacies) - Southern Africa

  • Southern Africa
  • Revenue in the Wound Care market is projected to reach US$8.13m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.87%, resulting in a market volume of US$8.49m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.12 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Southern Africa has been experiencing steady growth in recent years, driven by several key factors. Customer preferences in the region have played a significant role in the development of the Wound Care (Pharmacies) market. Southern African consumers are becoming increasingly health-conscious and are seeking out products that can help them manage and treat wounds effectively. As a result, there has been a growing demand for wound care products in pharmacies across the region. Trends in the market have also contributed to its development. One notable trend is the increasing prevalence of chronic diseases such as diabetes and obesity in Southern Africa. These conditions often result in slow-healing wounds, creating a need for specialized wound care products that can promote faster healing. Pharmacies have responded to this trend by expanding their range of wound care products, including advanced dressings and wound healing ointments. Another trend in the market is the growing adoption of advanced wound care technologies. Southern African pharmacies are now offering innovative products such as negative pressure wound therapy and bioactive wound dressings. These advanced technologies have been proven to accelerate wound healing and reduce the risk of infection, making them highly sought after by both healthcare professionals and patients. Local special circumstances have also influenced the development of the Wound Care (Pharmacies) market in Southern Africa. The region has a high burden of infectious diseases, such as HIV/AIDS and tuberculosis, which can lead to the development of chronic wounds. This has created a significant demand for wound care products that can effectively manage these complex wounds. Pharmacies have responded to this need by stocking a wide range of wound care products specifically designed for the treatment of infectious wounds. Underlying macroeconomic factors have also played a role in the growth of the Wound Care (Pharmacies) market in Southern Africa. The region has experienced steady economic growth in recent years, resulting in an expanding middle class with increased purchasing power. This has led to higher healthcare expenditure, including spending on wound care products. Additionally, improvements in healthcare infrastructure and access to healthcare services have made it easier for consumers to seek out and purchase wound care products from pharmacies. In conclusion, the Wound Care (Pharmacies) market in Southern Africa is developing due to customer preferences for effective wound care products, trends such as the increasing prevalence of chronic diseases and the adoption of advanced wound care technologies, local special circumstances such as a high burden of infectious diseases, and underlying macroeconomic factors including economic growth and improved healthcare infrastructure.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)